|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A report of ACC/AHA task force on assessment of diagnostic and therapeutic cardiovascular procedures显示文摘 | Ryan TJ Faxon DP Gunnar RM | 1988 | J Am Coll Cardiol1988，12，3： | 1 |
| 2 | Phase II trial of docetaxel,cisplatin,irinotecan,and bevacizumab in metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Regan EM | 2008 | J Clin Oncol2008，，： | 1 |
| 3 | A phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma显示文摘 | Ryan DP Kulke MH Fuchs CS | 2002 | Cancer2002，94，1： | 1 |
| 4 | Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12显示文摘 | Ryan DP Duncan JL Lee C | 2008 | Proteins2008，70，4： | 1 |
| 5 | Weekly docetaxel,cisplatin,and irinotecan(TPC):results of a multicenter phase Ⅱ trial in patients with metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Clark JW | 2009 | Ann Oncol2009，20，3： | 1 |
| 6 | NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘 | Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C | 2009 | J Natl Compr Canc Netw2009，7，： | 1 |
| 7 | A phase II study of modified deGramont 5-fluorouracil,leucovorin,and oxaliplatin in previously treated patients with metastatic colorectal cancer显示文摘 | Ryan DP Clark JW Kulke MH | 2003 | Cancer Invest2003，21，4： | 1 |
| 8 | Phase II trial of docetaxel, cisplatin, irinotecan, and bevacizumab in metastatic esophagogastric cancer显示文摘 | Enzinger PC Ryan DP Regan EM | 2008 | J Clin Oncol2008，26，： | 1 |
| 9 | Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer 显示文摘 | Kulke MH Blaszkowsky LS Ryan DP | 2007 | J Clin Oncol2007，25，30： | 1 |
| 10 | Role of the Bicoid-related homeodomain factor Pitxl in spe- cifying hindlimb morphogenesis and pituitary develop- ment显示文摘 | Szeto DP Rodriguez-Esteban C Ryan AK | 1999 | Genes Dev1999，13，4： | 1 |
| 11 | Capecitabi- ne plus erlotinib in gemcitabine-refractory advanced pan- creatic cancer显示文摘 | Kulke MH Blaszkowsky LS Ryan DP | 2007 | J Clin Oncol2007，25，30： | 1 |
| 12 | Phase Ⅰ clinical trial ofihe farnesyl transferase inhibitor BMS-214662 giVen as l-hour intravenous infusion in patients with advanced solid tumors显示文摘 | Ryan DP Eder Jr JP Puchlaski T | 2004 | Clin Cancer Bes2004，10，： | 1 |
| 13 | Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma 显示文摘 | Zhu AX Blaszkowsky LS Ryan DP | 2006 | J Clin Oncol2006，24，： | 1 |
| 14 | Guidelines for percutaneous transluminal coronary angioplasty:a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and the therapeutic cardiovascular procedures显示文摘 | Ryan TJ Faxon DP Gunnar RM | 1988 | Circulation1988，78，： | 1 |
| 15 | Rapamycin extends murine lifespan but has limited effects on aging显示文摘 | Neff F Flores-Dominguez D Ryan DP | 2013 | The Journal of Clinical Investigation2013，123，8： | 1 |
| 16 | Capeeitabine plus erlotinib in gemcitabine - refractory advanced pancreatic cancer 显示文摘 | Kulke MH Blaszkowsky LS Ryan DP | 2007 | J Clin Oncol2007，25，30： | 1 |
| 17 | Phase Ⅰ/Ⅱ study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukemia group B 89901 显示文摘 | Ryan DP Niedzwiecki D Hollis D | 2006 | J Clin Oncol2006，24，16： | 1 |
| 18 | The role of targeted agents in preoperative chemoradiation for rectal cancer显示文摘 | Wadlow RC Ryan DP | 2010 | Cancer2010，116，15： | 1 |
| 19 | Pancreatic adenocarcinoma显示文摘 | Ryan DP Hong TS Bardeesy N | 2014 | N Eegl J Med2014，371，： | 1 |
| 20 | Capeeitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer显示文摘 | Kulke MH Blaszkowsky LS Ryan DP | 2007 | J Clin Oncol2007，25，30： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员